![]() |
Volumn 20, Issue 10, 2002, Pages 2441-2452
|
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A cancer and leukemia group B study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZACITIDINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
ARTICLE;
CANCER RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISEASE COURSE;
DYSPNEA;
FEMALE;
HUMAN;
INSOMNIA;
INTERVIEW;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT TRANSFORMATION;
MORTALITY;
MYELODYSPLASTIC SYNDROME;
OUTCOMES RESEARCH;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SOCIAL ASPECT;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIMETABOLITES, ANTINEOPLASTIC;
AZACITIDINE;
FEMALE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
LEUKEMIA, B-CELL;
MALE;
MIDDLE AGED;
MYELODYSPLASTIC SYNDROMES;
QUALITY OF LIFE;
QUESTIONNAIRES;
REMISSION INDUCTION;
TREATMENT OUTCOME;
|
EID: 0037092962
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2002.04.044 Document Type: Article |
Times cited : (364)
|
References (18)
|